CORLINE BIOMEDICAL AB |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 10.55 SEK | -.--% |
|
-2.76% | -29.19% |
| Sales 2024 * | 36M 3.3M | Sales 2025 * | 179M 16.4M | Capitalization | 227M 20.77M |
|---|---|---|---|---|---|
| Net income 2024 * | -6M -550K | Net income 2025 * | 105M 9.62M | EV / Sales 2024 * | 5.74 x |
| Net cash position 2024 * | 20M 1.83M | Net cash position 2025 * | 118M 10.81M | EV / Sales 2025 * | 0.61 x |
| P/E ratio 2024 * |
-36.4
x | P/E ratio 2025 * |
2.16
x | Employees | 13 |
| Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 45.17% |
More Fundamentals
* Assessed data
More news
| 1 week | -2.76% | ||
| Current month | -11.34% | ||
| 1 month | -11.34% | ||
| 3 months | -28.47% | ||
| 6 months | -24.37% | ||
| Current year | -29.19% |
1 week
10.00
11.00
1 month
10.0012.65
Current year
10.0016.80
1 year
10.0019.85
3 years
7.6019.85
5 years
7.6026.60
10 years
6.4031.00
| Managers | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 58 | 07-12-31 | |
Gunnar Tufveson
CTO | Chief Tech/Sci/R&D Officer | - | 17-12-31 |
Magnus Nilsson
BRD | Director/Board Member | 68 | 20-11-17 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Magnus Nilsson
BRD | Director/Board Member | 68 | 20-11-17 |
| Director/Board Member | - | 04-12-31 | |
| Chairman | 51 | 04-12-31 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-04-30 | 10.55 | -.--% | 1,860 |
| 24-04-29 | 10.55 | +2.43% | 16,630 |
| 24-04-26 | 10.3 | +0.98% | 3,207 |
| 24-04-25 | 10.2 | -0.49% | 6,025 |
| 24-04-24 | 10.25 | -1.44% | 13,334 |
Delayed Quote Nasdaq Stockholm, April 30, 2024 at 06:31 am EDT
More quotes
Corline Biomedical AB is a Sweden-based biotechnology company. It develops, manufactures and markets heparin-based solutions to improve kidney transplantation, cell therapies and applications in regenerative medicine.
Sector
Pharmaceuticals
Calendar
2024-05-14
- Annual General Meeting
EPS Revisions
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -29.19% | 20.64M | |
| +12.26% | 9B | |
| -12.75% | 4.96B | |
| +42.38% | 4.47B | |
| +5.23% | 3.9B | |
| +20.51% | 2.45B | |
| -19.05% | 2.41B | |
| -28.72% | 2.23B | |
| +11.13% | 2.02B | |
| +3.94% | 1.65B |
- Stock Market
- Equities
- CLBIO Stock
